Suppr超能文献

抗聚乙二醇(PEG)抗体在含 PEG 的 COVID-19 疫苗过敏反应中的作用:PEG 具有免疫原性的证据。

Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG.

机构信息

Nanomedicine Research and Education Center, Department of Translational Medicine, Semmelweis University, Budapest, Hungary; SeroScience LLC, Budapest, Hungary.

Department of Radiology, BAZ County Central Hospital and Borsod County University Teaching Hospital and Miskolc University, Miskolc, Hungary.

出版信息

Vaccine. 2023 Jul 12;41(31):4561-4570. doi: 10.1016/j.vaccine.2023.06.009. Epub 2023 Jun 5.

Abstract

A small fraction of recipients who receive polyethylene-glycol (PEG)-containing COVID-19 mRNA-LNP vaccines (Comirnaty and Spikevax) develop hypersensitivity reactions (HSRs) or anaphylaxis. A causal role of anti-PEG antibodies (Abs) has been proposed, but not yet been proven in humans.We used ELISA for serial measurements of SARS-CoV-2 neutralizing Ab (anti-S) and anti-PEG IgG/IgM Ab levels before and after the first and subsequent booster vaccinations with mRNA-LNP vaccines in a total of 291 blood donors. The HSRs in 15 subjects were graded and correlated with anti-PEG IgG/IgM, just as the anti-S and anti-PEG Ab levels with each other. The impacts of gender, allergy, mastocytosis and use of cosmetics were also analyzed. Serial testing of two or more plasma samples showed substantial individual variation of anti-S Ab levels after repeated vaccinations, just as the levels of anti-PEG IgG and IgM, which were over baseline in 98-99 % of unvaccinated individuals. About 3-4 % of subjects in the strongly left-skewed distribution had 15-45-fold higher values than the median, referred to as anti-PEG Ab supercarriers. Both vaccines caused significant rises of anti-PEG IgG/IgM with >10-fold rises in about ∼10 % of Comirnaty, and all Spikevax recipients. The anti-PEG IgG and/or IgM levels in the 15 vaccine reactors (3 anaphylaxis) were significantly higher compared to nonreactors. Serial testing of plasma showed significant correlation between the booster injection-induced rises of anti-S and anti-PEG IgGs, suggesting coupled anti-S and anti-PEG immunogenicity.Conclusions: The small percentage of people who have extremelevels of anti-PEG Ab in their blood may be at increased risk for HSRs/anaphylaxis to PEGylated vaccines and other PEGylated injectables. This risk might be further increased by the anti-PEG immunogenicity of these vaccines. Screening for anti-PEG Ab "supercarriers" may help predicting reactors and thus preventing these adverse phenomena.

摘要

一小部分接受含有聚乙二醇(PEG)的 COVID-19 mRNA-LNP 疫苗(Comirnaty 和 Spikevax)的接种者会出现过敏反应(HSR)或过敏症。有人提出了抗 PEG 抗体(Abs)的因果作用,但尚未在人类中得到证实。我们使用 ELISA 对 291 名献血者进行了一系列测量,以检测在接受 mRNA-LNP 疫苗的首次和随后的加强针接种前后,SARS-CoV-2 中和抗体(抗 S)和抗 PEG IgG/IgM Ab 水平。在 15 名受试者中,HSR 被分级,并与抗 PEG IgG/IgM 相关,就像抗 S 和抗 PEG Ab 之间的关系一样。还分析了性别、过敏、肥大细胞增多症和化妆品的使用。对两个或更多血浆样本进行的连续检测显示,在多次接种后,抗 S Ab 水平会发生显著的个体差异,正如抗 PEG IgG 和 IgM 水平一样,在未接种疫苗的个体中,98-99%的个体基线以上。大约 3-4%的受试者在强烈偏左分布中有 15-45 倍高于中位数的值,称为抗 PEG Ab 超级载体。两种疫苗均导致抗 PEG IgG/IgM 显著升高,Comirnaty 约有>10%的患者升高 10 倍以上,所有接受 Spikevax 的患者均如此。与非反应者相比,15 名疫苗反应者(3 名过敏反应者)的抗 PEG IgG 和/或 IgM 水平显著升高。血浆的连续检测显示,加强针注射引起的抗 S 和抗 PEG IgGs 升高之间存在显著相关性,表明抗 S 和抗 PEG 的免疫原性耦合。结论:血液中抗 PEG Ab 水平极高的一小部分人可能对 PEG 化疫苗和其他 PEG 化注射剂的 HSR/过敏反应风险增加。这些疫苗的抗 PEG 免疫原性可能会进一步增加这种风险。筛选抗 PEG Ab“超级载体”可能有助于预测反应者,从而预防这些不良反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b6/10239905/d6fd2628c551/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验